Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association | SpringerLink
Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer | British Journal of Cancer
Frontiers | The Origins and Generation of Cancer-Associated Mesenchymal Stromal Cells: An Innovative Therapeutic Target for Solid Tumors
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions - Cheng - 2021 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
Comparison between CEA, CA 19-9 and CA 72-4 in Patients with Colon Cancer
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect
The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer - ScienceDirect
Tumor markers in cancer diagnosis and prognosis
CA 19-9: Reference Range, Interpretation, Collection and Panels
Tissue architecture in tumor initiation and progression: Trends in Cancer
Preoperative CA 125 Levels: An Independent Prognostic Factor for Epithelial Ovarian Cancer | Semantic Scholar
Cancer Tumor Markers - ELISA Blood Test Kits
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
Cancer biomarker - Wikipedia
Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries | Anticancer Research
Clinical risk factors of gastric cancer (GC) and tumor markers in high... | Download Scientific Diagram
Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study - eBioMedicine
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10 - eBioMedicine
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Review of the Journals
The distribution of tumour marker parameters | Download Table
Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
